Related Experiment Video
Updated: Jun 4, 2026
10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
Bariatric surgery in obese adolescents
Andrei Keidar1, Lior Hecht, Ram Weiss
1Department of Surgery, Hadassah Hebrew University Medical Center, Israel.
Current Opinion in Clinical Nutrition and Metabolic Care
|March 2, 2011
Summary
Bariatric surgery shows promise for treating severe obesity in adolescents, leading to significant weight loss and improved health. Further research is needed to define optimal patient selection and care protocols for this population.
Area of Science:
- Pediatric Endocrinology
- Bariatric Surgery
- Adolescent Health
Background:
- Morbid obesity in children is a growing concern with limited treatment options.
- Bariatric surgery is established for adults but understudied in pediatrics.
Purpose of the Study:
- To review recent advancements in bariatric surgery for obese children.
- To identify current knowledge gaps in the field.
Main Methods:
- Review of recent randomized controlled trials and case series on pediatric bariatric surgery.
- Analysis of safety, efficacy, and comorbidity resolution data.
Main Results:
- Studies demonstrate the relative safety and significant weight loss associated with bariatric surgery in adolescents.
- Obesity-related comorbidities frequently resolve post-surgery.
- Adverse psychological effects may be more common in adolescents than adults.
Conclusions:
- Bariatric procedures like gastric banding and bypass are effective and well-tolerated in select pediatric patients.
- Optimal patient selection, surgical technique, and multidisciplinary care require further definition.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...